Global Equine Pharmaceuticals and Supplements Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Equine Pharmaceuticals and Supplements market size is predicted to grow from US$ 1226 million in 2025 to US$ 1611 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.
In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.
LP Information, Inc. (LPI) ' newest research report, the “Equine Pharmaceuticals and Supplements Industry Forecast” looks at past sales and reviews total world Equine Pharmaceuticals and Supplements sales in 2024, providing a comprehensive analysis by region and market sector of projected Equine Pharmaceuticals and Supplements sales for 2025 through 2031. With Equine Pharmaceuticals and Supplements sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Equine Pharmaceuticals and Supplements industry.
This Insight Report provides a comprehensive analysis of the global Equine Pharmaceuticals and Supplements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Equine Pharmaceuticals and Supplements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Equine Pharmaceuticals and Supplements market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Equine Pharmaceuticals and Supplements and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Equine Pharmaceuticals and Supplements.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Pharmaceuticals and Supplements market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Equine Pharmaceuticals and Supplements market?
What factors are driving Equine Pharmaceuticals and Supplements market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Equine Pharmaceuticals and Supplements market opportunities vary by end market size?
How does Equine Pharmaceuticals and Supplements break out by Type, by Application?
The global Equine Pharmaceuticals and Supplements market size is predicted to grow from US$ 1226 million in 2025 to US$ 1611 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.
In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.
LP Information, Inc. (LPI) ' newest research report, the “Equine Pharmaceuticals and Supplements Industry Forecast” looks at past sales and reviews total world Equine Pharmaceuticals and Supplements sales in 2024, providing a comprehensive analysis by region and market sector of projected Equine Pharmaceuticals and Supplements sales for 2025 through 2031. With Equine Pharmaceuticals and Supplements sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Equine Pharmaceuticals and Supplements industry.
This Insight Report provides a comprehensive analysis of the global Equine Pharmaceuticals and Supplements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Equine Pharmaceuticals and Supplements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Equine Pharmaceuticals and Supplements market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Equine Pharmaceuticals and Supplements and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Equine Pharmaceuticals and Supplements.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Pharmaceuticals and Supplements market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Pharmaceuticals
- Supplements
- Thoroughbred Horse
- Other Types of Horses
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- Merck Animal Health
- Zoetis
- Bayer Animal Health
- Elanco Animal Health
- Dechra Veterinary Products
- CEVA
- Virbac
- Norbrook Equine
- Kyoritsu Seiyaku
- Vetoquinol
- Protexin Healthcare
- Audevard
- Ouro Fino Saude
What is the 10-year outlook for the global Equine Pharmaceuticals and Supplements market?
What factors are driving Equine Pharmaceuticals and Supplements market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Equine Pharmaceuticals and Supplements market opportunities vary by end market size?
How does Equine Pharmaceuticals and Supplements break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Equine Pharmaceuticals and Supplements by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Equine Pharmaceuticals and Supplements by Country/Region, 2020, 2024 & 2031
2.2 Equine Pharmaceuticals and Supplements Segment by Type
2.2.1 Pharmaceuticals
2.2.2 Supplements
2.3 Equine Pharmaceuticals and Supplements Sales by Type
2.3.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2025)
2.3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2020-2025)
2.3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Type (2020-2025)
2.4 Equine Pharmaceuticals and Supplements Segment by Application
2.4.1 Thoroughbred Horse
2.4.2 Other Types of Horses
2.5 Equine Pharmaceuticals and Supplements Sales by Application
2.5.1 Global Equine Pharmaceuticals and Supplements Sale Market Share by Application (2020-2025)
2.5.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Application (2020-2025)
2.5.3 Global Equine Pharmaceuticals and Supplements Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Equine Pharmaceuticals and Supplements Breakdown Data by Company
3.1.1 Global Equine Pharmaceuticals and Supplements Annual Sales by Company (2020-2025)
3.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Company (2020-2025)
3.2 Global Equine Pharmaceuticals and Supplements Annual Revenue by Company (2020-2025)
3.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Company (2020-2025)
3.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2020-2025)
3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Company
3.4 Key Manufacturers Equine Pharmaceuticals and Supplements Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Pharmaceuticals and Supplements Product Location Distribution
3.4.2 Players Equine Pharmaceuticals and Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EQUINE PHARMACEUTICALS AND SUPPLEMENTS BY GEOGRAPHIC REGION
4.1 World Historic Equine Pharmaceuticals and Supplements Market Size by Geographic Region (2020-2025)
4.1.1 Global Equine Pharmaceuticals and Supplements Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Equine Pharmaceuticals and Supplements Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Equine Pharmaceuticals and Supplements Market Size by Country/Region (2020-2025)
4.2.1 Global Equine Pharmaceuticals and Supplements Annual Sales by Country/Region (2020-2025)
4.2.2 Global Equine Pharmaceuticals and Supplements Annual Revenue by Country/Region (2020-2025)
4.3 Americas Equine Pharmaceuticals and Supplements Sales Growth
4.4 APAC Equine Pharmaceuticals and Supplements Sales Growth
4.5 Europe Equine Pharmaceuticals and Supplements Sales Growth
4.6 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Growth
5 AMERICAS
5.1 Americas Equine Pharmaceuticals and Supplements Sales by Country
5.1.1 Americas Equine Pharmaceuticals and Supplements Sales by Country (2020-2025)
5.1.2 Americas Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025)
5.2 Americas Equine Pharmaceuticals and Supplements Sales by Type (2020-2025)
5.3 Americas Equine Pharmaceuticals and Supplements Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Pharmaceuticals and Supplements Sales by Region
6.1.1 APAC Equine Pharmaceuticals and Supplements Sales by Region (2020-2025)
6.1.2 APAC Equine Pharmaceuticals and Supplements Revenue by Region (2020-2025)
6.2 APAC Equine Pharmaceuticals and Supplements Sales by Type (2020-2025)
6.3 APAC Equine Pharmaceuticals and Supplements Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Equine Pharmaceuticals and Supplements by Country
7.1.1 Europe Equine Pharmaceuticals and Supplements Sales by Country (2020-2025)
7.1.2 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025)
7.2 Europe Equine Pharmaceuticals and Supplements Sales by Type (2020-2025)
7.3 Europe Equine Pharmaceuticals and Supplements Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Equine Pharmaceuticals and Supplements by Country
8.1.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Country (2020-2025)
8.1.2 Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025)
8.2 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2020-2025)
8.3 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equine Pharmaceuticals and Supplements
10.3 Manufacturing Process Analysis of Equine Pharmaceuticals and Supplements
10.4 Industry Chain Structure of Equine Pharmaceuticals and Supplements
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equine Pharmaceuticals and Supplements Distributors
11.3 Equine Pharmaceuticals and Supplements Customer
12 WORLD FORECAST REVIEW FOR EQUINE PHARMACEUTICALS AND SUPPLEMENTS BY GEOGRAPHIC REGION
12.1 Global Equine Pharmaceuticals and Supplements Market Size Forecast by Region
12.1.1 Global Equine Pharmaceuticals and Supplements Forecast by Region (2026-2031)
12.1.2 Global Equine Pharmaceuticals and Supplements Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Equine Pharmaceuticals and Supplements Forecast by Type (2026-2031)
12.7 Global Equine Pharmaceuticals and Supplements Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Merck Animal Health
13.2.1 Merck Animal Health Company Information
13.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Animal Health Main Business Overview
13.2.5 Merck Animal Health Latest Developments
13.3 Zoetis
13.3.1 Zoetis Company Information
13.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Zoetis Main Business Overview
13.3.5 Zoetis Latest Developments
13.4 Bayer Animal Health
13.4.1 Bayer Animal Health Company Information
13.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Bayer Animal Health Main Business Overview
13.4.5 Bayer Animal Health Latest Developments
13.5 Elanco Animal Health
13.5.1 Elanco Animal Health Company Information
13.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Elanco Animal Health Main Business Overview
13.5.5 Elanco Animal Health Latest Developments
13.6 Dechra Veterinary Products
13.6.1 Dechra Veterinary Products Company Information
13.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Dechra Veterinary Products Main Business Overview
13.6.5 Dechra Veterinary Products Latest Developments
13.7 CEVA
13.7.1 CEVA Company Information
13.7.2 CEVA Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 CEVA Main Business Overview
13.7.5 CEVA Latest Developments
13.8 Virbac
13.8.1 Virbac Company Information
13.8.2 Virbac Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Virbac Main Business Overview
13.8.5 Virbac Latest Developments
13.9 Norbrook Equine
13.9.1 Norbrook Equine Company Information
13.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Norbrook Equine Main Business Overview
13.9.5 Norbrook Equine Latest Developments
13.10 Kyoritsu Seiyaku
13.10.1 Kyoritsu Seiyaku Company Information
13.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Kyoritsu Seiyaku Main Business Overview
13.10.5 Kyoritsu Seiyaku Latest Developments
13.11 Vetoquinol
13.11.1 Vetoquinol Company Information
13.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Vetoquinol Main Business Overview
13.11.5 Vetoquinol Latest Developments
13.12 Protexin Healthcare
13.12.1 Protexin Healthcare Company Information
13.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Protexin Healthcare Main Business Overview
13.12.5 Protexin Healthcare Latest Developments
13.13 Audevard
13.13.1 Audevard Company Information
13.13.2 Audevard Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Audevard Main Business Overview
13.13.5 Audevard Latest Developments
13.14 Ouro Fino Saude
13.14.1 Ouro Fino Saude Company Information
13.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Ouro Fino Saude Main Business Overview
13.14.5 Ouro Fino Saude Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Equine Pharmaceuticals and Supplements Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Equine Pharmaceuticals and Supplements Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pharmaceuticals
Table 4. Major Players of Supplements
Table 5. Global Equine Pharmaceuticals and Supplements Sales byType (2020-2025) & (K Units)
Table 6. Global Equine Pharmaceuticals and Supplements Sales Market Share byType (2020-2025)
Table 7. Global Equine Pharmaceuticals and Supplements Revenue byType (2020-2025) & ($ million)
Table 8. Global Equine Pharmaceuticals and Supplements Revenue Market Share byType (2020-2025)
Table 9. Global Equine Pharmaceuticals and Supplements Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Equine Pharmaceuticals and Supplements Sale by Application (2020-2025) & (K Units)
Table 11. Global Equine Pharmaceuticals and Supplements Sale Market Share by Application (2020-2025)
Table 12. Global Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & ($ million)
Table 13. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2025)
Table 14. Global Equine Pharmaceuticals and Supplements Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Equine Pharmaceuticals and Supplements Sales by Company (2020-2025) & (K Units)
Table 16. Global Equine Pharmaceuticals and Supplements Sales Market Share by Company (2020-2025)
Table 17. Global Equine Pharmaceuticals and Supplements Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2020-2025)
Table 19. Global Equine Pharmaceuticals and Supplements Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Equine Pharmaceuticals and Supplements Producing Area Distribution and Sales Area
Table 21. Players Equine Pharmaceuticals and Supplements Products Offered
Table 22. Equine Pharmaceuticals and Supplements Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Equine Pharmaceuticals and Supplements Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Equine Pharmaceuticals and Supplements Sales Market Share Geographic Region (2020-2025)
Table 27. Global Equine Pharmaceuticals and Supplements Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Equine Pharmaceuticals and Supplements Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Equine Pharmaceuticals and Supplements Sales Market Share by Country/Region (2020-2025)
Table 31. Global Equine Pharmaceuticals and Supplements Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 34. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Country (2020-2025)
Table 35. Americas Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Equine Pharmaceuticals and Supplements Sales byType (2020-2025) & (K Units)
Table 37. Americas Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Units)
Table 38. APAC Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K Units)
Table 39. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Region (2020-2025)
Table 40. APAC Equine Pharmaceuticals and Supplements Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Equine Pharmaceuticals and Supplements Sales byType (2020-2025) & (K Units)
Table 42. APAC Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Units)
Table 43. Europe Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 44. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Equine Pharmaceuticals and Supplements Sales byType (2020-2025) & (K Units)
Table 46. Europe Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Equine Pharmaceuticals and Supplements Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Equine Pharmaceuticals and Supplements
Table 52. Key Market Challenges & Risks of Equine Pharmaceuticals and Supplements
Table 53. Key IndustryTrends of Equine Pharmaceuticals and Supplements
Table 54. Equine Pharmaceuticals and Supplements Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Equine Pharmaceuticals and Supplements Distributors List
Table 57. Equine Pharmaceuticals and Supplements Customer List
Table 58. Global Equine Pharmaceuticals and Supplements SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Equine Pharmaceuticals and Supplements RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Equine Pharmaceuticals and Supplements SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Equine Pharmaceuticals and Supplements Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Equine Pharmaceuticals and Supplements SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Equine Pharmaceuticals and Supplements Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Equine Pharmaceuticals and Supplements SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Equine Pharmaceuticals and Supplements RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Equine Pharmaceuticals and Supplements SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Equine Pharmaceuticals and Supplements RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Equine Pharmaceuticals and Supplements SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Equine Pharmaceuticals and Supplements RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Equine Pharmaceuticals and Supplements SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Equine Pharmaceuticals and Supplements RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Boehringer Ingelheim Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 73. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 74. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Boehringer Ingelheim Main Business
Table 76. Boehringer Ingelheim Latest Developments
Table 77. Merck Animal Health Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 79. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Merck Animal Health Main Business
Table 81. Merck Animal Health Latest Developments
Table 82. Zoetis Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 83. Zoetis Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 84. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Zoetis Main Business
Table 86. Zoetis Latest Developments
Table 87. Bayer Animal Health Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 88. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 89. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Bayer Animal Health Main Business
Table 91. Bayer Animal Health Latest Developments
Table 92. Elanco Animal Health Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 93. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 94. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Elanco Animal Health Main Business
Table 96. Elanco Animal Health Latest Developments
Table 97. Dechra Veterinary Products Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 98. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 99. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Dechra Veterinary Products Main Business
Table 101. Dechra Veterinary Products Latest Developments
Table 102. CEVA Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 103. CEVA Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 104. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. CEVA Main Business
Table 106. CEVA Latest Developments
Table 107. Virbac Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 108. Virbac Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 109. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Virbac Main Business
Table 111. Virbac Latest Developments
Table 112. Norbrook Equine Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 113. Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 114. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Norbrook Equine Main Business
Table 116. Norbrook Equine Latest Developments
Table 117. Kyoritsu Seiyaku Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 118. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 119. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Kyoritsu Seiyaku Main Business
Table 121. Kyoritsu Seiyaku Latest Developments
Table 122. Vetoquinol Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 123. Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 124. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Vetoquinol Main Business
Table 126. Vetoquinol Latest Developments
Table 127. Protexin Healthcare Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 128. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 129. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Protexin Healthcare Main Business
Table 131. Protexin Healthcare Latest Developments
Table 132. Audevard Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 133. Audevard Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 134. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Audevard Main Business
Table 136. Audevard Latest Developments
Table 137. OuroFino Saude Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 138. OuroFino Saude Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 139. OuroFino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. OuroFino Saude Main Business
Table 141. OuroFino Saude Latest Developments
LIST OFFIGURES
Figure 1. Picture of Equine Pharmaceuticals and Supplements
Figure 2. Equine Pharmaceuticals and Supplements Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Pharmaceuticals and Supplements Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Equine Pharmaceuticals and Supplements Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Equine Pharmaceuticals and Supplements Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Equine Pharmaceuticals and Supplements Sales Market Share by Country/Region (2024)
Figure 10. Equine Pharmaceuticals and Supplements Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Pharmaceuticals
Figure 12. Product Picture of Supplements
Figure 13. Global Equine Pharmaceuticals and Supplements Sales Market Share byType in 2025
Figure 14. Global Equine Pharmaceuticals and Supplements Revenue Market Share byType (2020-2025)
Figure 15. Equine Pharmaceuticals and Supplements Consumed inThoroughbred Horse
Figure 16. Global Equine Pharmaceuticals and Supplements Market:Thoroughbred Horse (2020-2025) & (K Units)
Figure 17. Equine Pharmaceuticals and Supplements Consumed in OtherTypes of Horses
Figure 18. Global Equine Pharmaceuticals and Supplements Market: OtherTypes of Horses (2020-2025) & (K Units)
Figure 19. Global Equine Pharmaceuticals and Supplements Sale Market Share by Application (2024)
Figure 20. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application in 2025
Figure 21. Equine Pharmaceuticals and Supplements Sales by Company in 2025 (K Units)
Figure 22. Global Equine Pharmaceuticals and Supplements Sales Market Share by Company in 2025
Figure 23. Equine Pharmaceuticals and Supplements Revenue by Company in 2025 ($ millions)
Figure 24. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company in 2025
Figure 25. Global Equine Pharmaceuticals and Supplements Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Equine Pharmaceuticals and Supplements Sales 2020-2025 (K Units)
Figure 28. Americas Equine Pharmaceuticals and Supplements Revenue 2020-2025 ($ millions)
Figure 29. APAC Equine Pharmaceuticals and Supplements Sales 2020-2025 (K Units)
Figure 30. APAC Equine Pharmaceuticals and Supplements Revenue 2020-2025 ($ millions)
Figure 31. Europe Equine Pharmaceuticals and Supplements Sales 2020-2025 (K Units)
Figure 32. Europe Equine Pharmaceuticals and Supplements Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Equine Pharmaceuticals and Supplements Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue 2020-2025 ($ millions)
Figure 35. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2025
Figure 36. Americas Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2020-2025)
Figure 37. Americas Equine Pharmaceuticals and Supplements Sales Market Share byType (2020-2025)
Figure 38. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 39. United States Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2025
Figure 44. APAC Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2025)
Figure 45. APAC Equine Pharmaceuticals and Supplements Sales Market Share byType (2020-2025)
Figure 46. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 47. China Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 51. India Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2025
Figure 55. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2020-2025)
Figure 56. Europe Equine Pharmaceuticals and Supplements Sales Market Share byType (2020-2025)
Figure 57. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 58. Germany Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 59.France Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 66. Egypt Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Equine Pharmaceuticals and Supplements in 2025
Figure 72. Manufacturing Process Analysis of Equine Pharmaceuticals and Supplements
Figure 73. Industry Chain Structure of Equine Pharmaceuticals and Supplements
Figure 74. Channels of Distribution
Figure 75. Global Equine Pharmaceuticals and Supplements Sales MarketForecast by Region (2026-2031)
Figure 76. Global Equine Pharmaceuticals and Supplements Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Equine Pharmaceuticals and Supplements Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Equine Pharmaceuticals and Supplements Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Equine Pharmaceuticals and Supplements Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Equine Pharmaceuticals and Supplements Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Equine Pharmaceuticals and Supplements by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Equine Pharmaceuticals and Supplements by Country/Region, 2020, 2024 & 2031
2.2 Equine Pharmaceuticals and Supplements Segment by Type
2.2.1 Pharmaceuticals
2.2.2 Supplements
2.3 Equine Pharmaceuticals and Supplements Sales by Type
2.3.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2025)
2.3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2020-2025)
2.3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Type (2020-2025)
2.4 Equine Pharmaceuticals and Supplements Segment by Application
2.4.1 Thoroughbred Horse
2.4.2 Other Types of Horses
2.5 Equine Pharmaceuticals and Supplements Sales by Application
2.5.1 Global Equine Pharmaceuticals and Supplements Sale Market Share by Application (2020-2025)
2.5.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Application (2020-2025)
2.5.3 Global Equine Pharmaceuticals and Supplements Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Equine Pharmaceuticals and Supplements Breakdown Data by Company
3.1.1 Global Equine Pharmaceuticals and Supplements Annual Sales by Company (2020-2025)
3.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Company (2020-2025)
3.2 Global Equine Pharmaceuticals and Supplements Annual Revenue by Company (2020-2025)
3.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Company (2020-2025)
3.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2020-2025)
3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Company
3.4 Key Manufacturers Equine Pharmaceuticals and Supplements Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Pharmaceuticals and Supplements Product Location Distribution
3.4.2 Players Equine Pharmaceuticals and Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EQUINE PHARMACEUTICALS AND SUPPLEMENTS BY GEOGRAPHIC REGION
4.1 World Historic Equine Pharmaceuticals and Supplements Market Size by Geographic Region (2020-2025)
4.1.1 Global Equine Pharmaceuticals and Supplements Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Equine Pharmaceuticals and Supplements Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Equine Pharmaceuticals and Supplements Market Size by Country/Region (2020-2025)
4.2.1 Global Equine Pharmaceuticals and Supplements Annual Sales by Country/Region (2020-2025)
4.2.2 Global Equine Pharmaceuticals and Supplements Annual Revenue by Country/Region (2020-2025)
4.3 Americas Equine Pharmaceuticals and Supplements Sales Growth
4.4 APAC Equine Pharmaceuticals and Supplements Sales Growth
4.5 Europe Equine Pharmaceuticals and Supplements Sales Growth
4.6 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Growth
5 AMERICAS
5.1 Americas Equine Pharmaceuticals and Supplements Sales by Country
5.1.1 Americas Equine Pharmaceuticals and Supplements Sales by Country (2020-2025)
5.1.2 Americas Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025)
5.2 Americas Equine Pharmaceuticals and Supplements Sales by Type (2020-2025)
5.3 Americas Equine Pharmaceuticals and Supplements Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Pharmaceuticals and Supplements Sales by Region
6.1.1 APAC Equine Pharmaceuticals and Supplements Sales by Region (2020-2025)
6.1.2 APAC Equine Pharmaceuticals and Supplements Revenue by Region (2020-2025)
6.2 APAC Equine Pharmaceuticals and Supplements Sales by Type (2020-2025)
6.3 APAC Equine Pharmaceuticals and Supplements Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Equine Pharmaceuticals and Supplements by Country
7.1.1 Europe Equine Pharmaceuticals and Supplements Sales by Country (2020-2025)
7.1.2 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025)
7.2 Europe Equine Pharmaceuticals and Supplements Sales by Type (2020-2025)
7.3 Europe Equine Pharmaceuticals and Supplements Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Equine Pharmaceuticals and Supplements by Country
8.1.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Country (2020-2025)
8.1.2 Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025)
8.2 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2020-2025)
8.3 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equine Pharmaceuticals and Supplements
10.3 Manufacturing Process Analysis of Equine Pharmaceuticals and Supplements
10.4 Industry Chain Structure of Equine Pharmaceuticals and Supplements
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equine Pharmaceuticals and Supplements Distributors
11.3 Equine Pharmaceuticals and Supplements Customer
12 WORLD FORECAST REVIEW FOR EQUINE PHARMACEUTICALS AND SUPPLEMENTS BY GEOGRAPHIC REGION
12.1 Global Equine Pharmaceuticals and Supplements Market Size Forecast by Region
12.1.1 Global Equine Pharmaceuticals and Supplements Forecast by Region (2026-2031)
12.1.2 Global Equine Pharmaceuticals and Supplements Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Equine Pharmaceuticals and Supplements Forecast by Type (2026-2031)
12.7 Global Equine Pharmaceuticals and Supplements Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Merck Animal Health
13.2.1 Merck Animal Health Company Information
13.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Animal Health Main Business Overview
13.2.5 Merck Animal Health Latest Developments
13.3 Zoetis
13.3.1 Zoetis Company Information
13.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Zoetis Main Business Overview
13.3.5 Zoetis Latest Developments
13.4 Bayer Animal Health
13.4.1 Bayer Animal Health Company Information
13.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Bayer Animal Health Main Business Overview
13.4.5 Bayer Animal Health Latest Developments
13.5 Elanco Animal Health
13.5.1 Elanco Animal Health Company Information
13.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Elanco Animal Health Main Business Overview
13.5.5 Elanco Animal Health Latest Developments
13.6 Dechra Veterinary Products
13.6.1 Dechra Veterinary Products Company Information
13.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Dechra Veterinary Products Main Business Overview
13.6.5 Dechra Veterinary Products Latest Developments
13.7 CEVA
13.7.1 CEVA Company Information
13.7.2 CEVA Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 CEVA Main Business Overview
13.7.5 CEVA Latest Developments
13.8 Virbac
13.8.1 Virbac Company Information
13.8.2 Virbac Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Virbac Main Business Overview
13.8.5 Virbac Latest Developments
13.9 Norbrook Equine
13.9.1 Norbrook Equine Company Information
13.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Norbrook Equine Main Business Overview
13.9.5 Norbrook Equine Latest Developments
13.10 Kyoritsu Seiyaku
13.10.1 Kyoritsu Seiyaku Company Information
13.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Kyoritsu Seiyaku Main Business Overview
13.10.5 Kyoritsu Seiyaku Latest Developments
13.11 Vetoquinol
13.11.1 Vetoquinol Company Information
13.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Vetoquinol Main Business Overview
13.11.5 Vetoquinol Latest Developments
13.12 Protexin Healthcare
13.12.1 Protexin Healthcare Company Information
13.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Protexin Healthcare Main Business Overview
13.12.5 Protexin Healthcare Latest Developments
13.13 Audevard
13.13.1 Audevard Company Information
13.13.2 Audevard Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Audevard Main Business Overview
13.13.5 Audevard Latest Developments
13.14 Ouro Fino Saude
13.14.1 Ouro Fino Saude Company Information
13.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
13.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Ouro Fino Saude Main Business Overview
13.14.5 Ouro Fino Saude Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Equine Pharmaceuticals and Supplements Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Equine Pharmaceuticals and Supplements Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pharmaceuticals
Table 4. Major Players of Supplements
Table 5. Global Equine Pharmaceuticals and Supplements Sales byType (2020-2025) & (K Units)
Table 6. Global Equine Pharmaceuticals and Supplements Sales Market Share byType (2020-2025)
Table 7. Global Equine Pharmaceuticals and Supplements Revenue byType (2020-2025) & ($ million)
Table 8. Global Equine Pharmaceuticals and Supplements Revenue Market Share byType (2020-2025)
Table 9. Global Equine Pharmaceuticals and Supplements Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Equine Pharmaceuticals and Supplements Sale by Application (2020-2025) & (K Units)
Table 11. Global Equine Pharmaceuticals and Supplements Sale Market Share by Application (2020-2025)
Table 12. Global Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & ($ million)
Table 13. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2025)
Table 14. Global Equine Pharmaceuticals and Supplements Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Equine Pharmaceuticals and Supplements Sales by Company (2020-2025) & (K Units)
Table 16. Global Equine Pharmaceuticals and Supplements Sales Market Share by Company (2020-2025)
Table 17. Global Equine Pharmaceuticals and Supplements Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2020-2025)
Table 19. Global Equine Pharmaceuticals and Supplements Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Equine Pharmaceuticals and Supplements Producing Area Distribution and Sales Area
Table 21. Players Equine Pharmaceuticals and Supplements Products Offered
Table 22. Equine Pharmaceuticals and Supplements Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Equine Pharmaceuticals and Supplements Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Equine Pharmaceuticals and Supplements Sales Market Share Geographic Region (2020-2025)
Table 27. Global Equine Pharmaceuticals and Supplements Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Equine Pharmaceuticals and Supplements Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Equine Pharmaceuticals and Supplements Sales Market Share by Country/Region (2020-2025)
Table 31. Global Equine Pharmaceuticals and Supplements Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 34. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Country (2020-2025)
Table 35. Americas Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Equine Pharmaceuticals and Supplements Sales byType (2020-2025) & (K Units)
Table 37. Americas Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Units)
Table 38. APAC Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K Units)
Table 39. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Region (2020-2025)
Table 40. APAC Equine Pharmaceuticals and Supplements Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Equine Pharmaceuticals and Supplements Sales byType (2020-2025) & (K Units)
Table 42. APAC Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Units)
Table 43. Europe Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 44. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Equine Pharmaceuticals and Supplements Sales byType (2020-2025) & (K Units)
Table 46. Europe Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Equine Pharmaceuticals and Supplements Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Equine Pharmaceuticals and Supplements
Table 52. Key Market Challenges & Risks of Equine Pharmaceuticals and Supplements
Table 53. Key IndustryTrends of Equine Pharmaceuticals and Supplements
Table 54. Equine Pharmaceuticals and Supplements Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Equine Pharmaceuticals and Supplements Distributors List
Table 57. Equine Pharmaceuticals and Supplements Customer List
Table 58. Global Equine Pharmaceuticals and Supplements SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Equine Pharmaceuticals and Supplements RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Equine Pharmaceuticals and Supplements SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Equine Pharmaceuticals and Supplements Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Equine Pharmaceuticals and Supplements SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Equine Pharmaceuticals and Supplements Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Equine Pharmaceuticals and Supplements SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Equine Pharmaceuticals and Supplements RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Equine Pharmaceuticals and Supplements SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Equine Pharmaceuticals and Supplements RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Equine Pharmaceuticals and Supplements SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Equine Pharmaceuticals and Supplements RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Equine Pharmaceuticals and Supplements SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Equine Pharmaceuticals and Supplements RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Boehringer Ingelheim Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 73. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 74. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Boehringer Ingelheim Main Business
Table 76. Boehringer Ingelheim Latest Developments
Table 77. Merck Animal Health Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 79. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Merck Animal Health Main Business
Table 81. Merck Animal Health Latest Developments
Table 82. Zoetis Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 83. Zoetis Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 84. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Zoetis Main Business
Table 86. Zoetis Latest Developments
Table 87. Bayer Animal Health Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 88. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 89. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Bayer Animal Health Main Business
Table 91. Bayer Animal Health Latest Developments
Table 92. Elanco Animal Health Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 93. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 94. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Elanco Animal Health Main Business
Table 96. Elanco Animal Health Latest Developments
Table 97. Dechra Veterinary Products Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 98. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 99. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Dechra Veterinary Products Main Business
Table 101. Dechra Veterinary Products Latest Developments
Table 102. CEVA Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 103. CEVA Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 104. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. CEVA Main Business
Table 106. CEVA Latest Developments
Table 107. Virbac Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 108. Virbac Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 109. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Virbac Main Business
Table 111. Virbac Latest Developments
Table 112. Norbrook Equine Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 113. Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 114. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Norbrook Equine Main Business
Table 116. Norbrook Equine Latest Developments
Table 117. Kyoritsu Seiyaku Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 118. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 119. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Kyoritsu Seiyaku Main Business
Table 121. Kyoritsu Seiyaku Latest Developments
Table 122. Vetoquinol Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 123. Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 124. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Vetoquinol Main Business
Table 126. Vetoquinol Latest Developments
Table 127. Protexin Healthcare Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 128. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 129. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Protexin Healthcare Main Business
Table 131. Protexin Healthcare Latest Developments
Table 132. Audevard Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 133. Audevard Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 134. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Audevard Main Business
Table 136. Audevard Latest Developments
Table 137. OuroFino Saude Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 138. OuroFino Saude Equine Pharmaceuticals and Supplements Product Portfolios and Specifications
Table 139. OuroFino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. OuroFino Saude Main Business
Table 141. OuroFino Saude Latest Developments
LIST OFFIGURES
Figure 1. Picture of Equine Pharmaceuticals and Supplements
Figure 2. Equine Pharmaceuticals and Supplements Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Pharmaceuticals and Supplements Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Equine Pharmaceuticals and Supplements Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Equine Pharmaceuticals and Supplements Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Equine Pharmaceuticals and Supplements Sales Market Share by Country/Region (2024)
Figure 10. Equine Pharmaceuticals and Supplements Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Pharmaceuticals
Figure 12. Product Picture of Supplements
Figure 13. Global Equine Pharmaceuticals and Supplements Sales Market Share byType in 2025
Figure 14. Global Equine Pharmaceuticals and Supplements Revenue Market Share byType (2020-2025)
Figure 15. Equine Pharmaceuticals and Supplements Consumed inThoroughbred Horse
Figure 16. Global Equine Pharmaceuticals and Supplements Market:Thoroughbred Horse (2020-2025) & (K Units)
Figure 17. Equine Pharmaceuticals and Supplements Consumed in OtherTypes of Horses
Figure 18. Global Equine Pharmaceuticals and Supplements Market: OtherTypes of Horses (2020-2025) & (K Units)
Figure 19. Global Equine Pharmaceuticals and Supplements Sale Market Share by Application (2024)
Figure 20. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application in 2025
Figure 21. Equine Pharmaceuticals and Supplements Sales by Company in 2025 (K Units)
Figure 22. Global Equine Pharmaceuticals and Supplements Sales Market Share by Company in 2025
Figure 23. Equine Pharmaceuticals and Supplements Revenue by Company in 2025 ($ millions)
Figure 24. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company in 2025
Figure 25. Global Equine Pharmaceuticals and Supplements Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Equine Pharmaceuticals and Supplements Sales 2020-2025 (K Units)
Figure 28. Americas Equine Pharmaceuticals and Supplements Revenue 2020-2025 ($ millions)
Figure 29. APAC Equine Pharmaceuticals and Supplements Sales 2020-2025 (K Units)
Figure 30. APAC Equine Pharmaceuticals and Supplements Revenue 2020-2025 ($ millions)
Figure 31. Europe Equine Pharmaceuticals and Supplements Sales 2020-2025 (K Units)
Figure 32. Europe Equine Pharmaceuticals and Supplements Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Equine Pharmaceuticals and Supplements Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue 2020-2025 ($ millions)
Figure 35. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2025
Figure 36. Americas Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2020-2025)
Figure 37. Americas Equine Pharmaceuticals and Supplements Sales Market Share byType (2020-2025)
Figure 38. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 39. United States Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2025
Figure 44. APAC Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2025)
Figure 45. APAC Equine Pharmaceuticals and Supplements Sales Market Share byType (2020-2025)
Figure 46. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 47. China Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 51. India Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2025
Figure 55. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2020-2025)
Figure 56. Europe Equine Pharmaceuticals and Supplements Sales Market Share byType (2020-2025)
Figure 57. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 58. Germany Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 59.France Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 66. Egypt Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Equine Pharmaceuticals and Supplements Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Equine Pharmaceuticals and Supplements in 2025
Figure 72. Manufacturing Process Analysis of Equine Pharmaceuticals and Supplements
Figure 73. Industry Chain Structure of Equine Pharmaceuticals and Supplements
Figure 74. Channels of Distribution
Figure 75. Global Equine Pharmaceuticals and Supplements Sales MarketForecast by Region (2026-2031)
Figure 76. Global Equine Pharmaceuticals and Supplements Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Equine Pharmaceuticals and Supplements Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Equine Pharmaceuticals and Supplements Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Equine Pharmaceuticals and Supplements Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Equine Pharmaceuticals and Supplements Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Equine Pharmaceuticals and Supplements Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
June 2026
106 pages
